Collegium Pharmaceutical (COLL) Other Non Operating Income (2014 - 2025)
Collegium Pharmaceutical (COLL) recorded quarterly Other Non Operating Income of -$16.0 million in Q4 2025, down 285.86% quarter-over-quarter from -$4.1 million in Q3 2024.
Collegium Pharmaceutical (COLL) Other Non Operating Income (2014 - 2025) Analysis & Trends
Collegium Pharmaceutical's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$16.0 million for Q4 2025.
- In Q4 2025, Other Non Operating Income changed N/A year-over-year to -$16.0 million; the TTM figure through Dec 2025 stood at -$16.0 million (down 41.18% YoY), while the FY2025 annual figure was -$16.0 million, down 41.18% from the prior year.
- Other Non Operating Income was -$16.0 million for Q4 2025 at Collegium Pharmaceutical, down from -$4.1 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $23.5 million in Q1 2023 to a low of -$47.0 million in Q2 2023.
- Historically, Other Non Operating Income has averaged -$10.2 million across 3 years, with a median of -$7.2 million in 2024.
- Biggest YoY gain for Other Non Operating Income was 84.72% in 2024; the steepest drop was 84.72% in 2024.
- A 3-year view of Other Non Operating Income shows it stood at -$47.0 million in 2023, then soared by 91.18% to -$4.1 million in 2024, then slumped by 285.86% to -$16.0 million in 2025.
- The last three Other Non Operating Income figures came in at -$16.0 million (Q4 2025), -$4.1 million (Q3 2024), and -$7.2 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.99 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Jun 30, 2024 | -7.18 Mn |
| Jun 30, 2023 | -47.01 Mn |
| Mar 31, 2023 | 23.50 Mn |
| Dec 31, 2017 | 180,000.00 |
| Sep 30, 2017 | 167,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Mar 31, 2017 | 98,000.00 |
| Dec 31, 2016 | 20,000.00 |
| Sep 30, 2016 | -2,000.00 |
| Jun 30, 2016 | -46,000.00 |
| Mar 31, 2016 | -66,000.00 |
| Dec 31, 2015 | -89,000.00 |
| Sep 30, 2015 | -97,000.00 |
| Jun 30, 2015 | -99,000.00 |
| Mar 31, 2015 | 91,000.00 |
| Dec 31, 2014 | -142,000.00 |
| Sep 30, 2014 | -51,000.00 |
| Jun 30, 2014 | -29,000.00 |